Pharvaris：一种分子有望重塑 HAE 治疗的两端 (NASDAQ:PHVS)
· seekingalpha.com
Pharvaris 正致力于通过其 deucrictibant 立即释放剂型打造一个垂直整合的 HAE 特许经营权。了解为什么 PHVS 股票值得买入。
The basis for my bullish Pharvaris ( PHVS ) thesis goes beyond the potential approval of an oral treatment for acute hereditary angioedema (HAE) attacks. The mo...